DRX008A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DRX008A, covering 2014-06-23 to 2014-06-23. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT) [Phase 1, Phase 2]